Mechanisms of equine recurrent airway obstruction: changes in understanding and management

Recurrent airway obstruction (RAO) is an inflammatory and obstructive disease that is more prevalent in horses stabled for long periods. The most common clinical signs include cough, exercise intolerance, dyspnea, nasal secretion and absence of fever. The pathophysiological effects of RAO in the lungs include goblet cell metaplasia, alveolar fibrosis, neovascularization, airway wall thickening affecting all tissue layers, and bronchial smooth muscle hypertrophy. The alveolar macrophage is the main effector of particle elimination in the inflammatory process of RAO, with the ability to increase or suppress inflammatory responses. Activation of macrophages increases the release of cytokines that enhance the inflammatory reaction, such as interleukin-1, tumor necrosis factor alpha, and interleukin-8, resulting in the attraction of neutrophils to the alveolar environment, which becomes the predominant cell type during periods of crisis. Although the clinical signs of RAO are well-defined, the underlying immunologic mechanisms are still being investigated. This review provides information about this disease, the understanding of which has changedover time.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-05-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.7213/ACADEMICA.15.2017.03
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory Airway Disease of Horses—Revised Consensus Statement

  2016cited by this paper
• Neutrophil and macrophage apoptosis in bronchoalveolar lavage fluid from healthy horses and horses with recurrent airway obstruction (RAO)

  2014cited by this paper
• Evaluation of Coughing and Nasal Discharge as Early Indicators for An Increased Risk to Develop Equine Recurrent Airway Obstruction (RAO)

  2014cited by this paper
• Effect of potential therapeutic agents in reducing oxidative stress in pulmonary tissues of recurrent airway obstruction-affected and clinically healthy horses.

  2013cited by this paper
• Respiratory diseases and their effects on respiratory function and exercise capacity.

  2013cited by this paper
• Cytokine targets in airway inflammation.

  2013cited by this paper
• Pulmonary intravascular macrophages as proinflammatory cells in heaves, an asthma-like equine disease.

  2012cited by this paper
• INVITED REVIEW SERIES: CUTTING EDGE TECHNOLOGIES

  2011cited by this paper
• CXCL8 attenuates chemoattractant-induced equine neutrophil migration.

  2011cited by this paper
• Diagnostic Approaches for the Assessment of Equine Chronic Pulmonary Disorders

  2011cited by this paper
• Effect of antigenic exposure on airway smooth muscle remodeling in an equine model of chronic asthma.

  2011cited by this paper
• Cytokine mRNA expression of pulmonary macrophages varies with challenge but not with disease state in horses with heaves or in controls.

  2011cited by this paper
• Update on Macrophage Clearance of Inhaled Micro- and Nanoparticles

  2010cited by this paper
• Environment and prednisone interactions in the treatment of recurrent airway obstruction (heaves).

  2010cited by this paper
• Efficacy of three corticosteroids for the treatment of heaves.

  2010influential reference
• Airway smooth muscle as an immunomodulatory cell.

  2009cited by this paper
• Recurrent Airway Obstruction ( Heaves )

  2009cited by this paper
• The effect of adding oral dexamethasone to feed alterations on the airway cell inflammatory gene expression in stabled horses affected with recurrent airway obstruction.

  2008cited by this paper
• Lung function and airway cytologic profiles in horses with recurrent airway obstruction maintained in low-dust environments.

  2007cited by this paper
• Cellular basis of chronic obstructive pulmonary disease in horses.

  2007cited by this paper
• The role of alveolar macrophages in the pathogenesis of recurrent airway obstruction in horses.

  2006cited by this paper
• Heaves, an asthma-like equine disease, involves airway smooth muscle remodeling.

  2006influential reference
• Toward functional proteomics of alveolar macrophages.

  2005cited by this paper
• Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells.

  2005cited by this paper
• IL-4 induced CD23 (FcepsilonRII) up-regulation in equine peripheral blood mononuclear cells and pulmonary alveolar macrophages.

  2004cited by this paper
• Cytokines in asthma

  2004cited by this paper
• Bronchiectasis in three adult horses with heaves.

  2004cited by this paper
• Hypersensitivity pneumonitis in the horse: an underdiagnosed condition?

  2004cited by this paper
• IL-4, IL-5 and IFN-γ mRNA expression in pulmonary lymphocytes in equine heaves

  2004cited by this paper
• Recurrent airway obstruction (RAO) in horses is characterized by IFN-gamma and IL-8 production in bronchoalveolar lavage cells.

  2003cited by this paper
• Airway remodeling in asthma: new insights.

  2003cited by this paper
• Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust‐induced asthma)

  2003cited by this paper
• The effect of aging on T cell responses in the horse.

  2002influential reference
• Chronic obstructive pulmonary disease.

  2002cited by this paper
• A novel model for equine recurrent airway obstruction.

  2002cited by this paper
• Characterization of equine E‐selectin

  2001cited by this paper
• IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.

  2001cited by this paper
• Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile.

  2001cited by this paper
• Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo.

  2000cited by this paper
• Concentrations of elastinolytic metalloproteinases in respiratory tract secretions of healthy horses and horses with chronic obstructive pulmonary disease.

  2000cited by this paper
• Priming of alveolar macrophages by leukotriene D(4): potentiation of inflammation.

  2000cited by this paper
• Airway neutrophils and interleukin-17.

  2000cited by this paper
• Mediators of anaphylaxis but not activated neutrophils augment cholinergic responses of equine small airways.

  1999cited by this paper
• The role of neutrophil chemotactic cytokines in the pathogenesis of equine chronic obstructive pulmonary disease (COPD).

  1998cited by this paper
• Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively.

  1998cited by this paper
• Selectins and their ligands: current concepts and controversies.

  1996cited by this paper
• Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes.

  1996cited by this paper
• The analysis and interpretation of equine bronchoalveolar lavage fluid (BALF) cytology

  1994cited by this paper
• Summer pasture-associated obstructive pulmonary disease in horses: 21 cases (1983-1991).

  1993cited by this paper
• Tissue destruction by neutrophils.

  1989cited by this paper
• Veterinary Immunology: An Introduction

  1987cited by this paper
• Bronchoalveolar lavage in ponies with recurrent airway obstruction (heaves).

  1985cited by this paper
• Some aspects of chronic pulmonary diseases of horses and methods used in their investigation.

  1974cited by this paper

• No citing papers are available for this paper.